WESTMINSTER, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- BioLargo, Inc. (OTCQB:BLGO), an innovator of sustainable science and
technology and full-service environmental engineering company, announced today that its Canadian subsidiary has received a
commitment of up to CA$235,000 for a pre-commercial pilot project for its Advanced Oxidation System (AOS) for on-site treatment of
poultry processing wastewater at a potential client’s poultry processing facility. The funding will be provided by the National
Research Council of Canada Industrial Research Assistance Program (NRC IRAP), Canada's premier industrial innovation assistance
program for small and medium-sized enterprises (SMEs). With this support, BioLargo’s AOS has received approximately CA$500,000 in
total contributions to date from the NRC IRAP. The pilot will demonstrate the AOS’ ability to disinfect and decontaminate water at
high flow-rates, allowing for recycling, reuse, and/or safe water discharge. Moreover, continuous treatment and recycling of
the processed water in this pilot project will allow for a comprehensive assessment of the long term economic advantage (both
operating and capital costs) and conservation benefits of the AOS for both energy and water, in comparison with conventional
wastewater treatment technologies. Ultimately, the company expects the results of this pilot will lay an important foundation for
the technical and business case that convinces future customers to purchase the AOS.
This pilot project and the NRC IRAP funding that supports it represents an important milestone in the company’s efforts to
develop and commercialize the AOS, its patented and innovative water treatment platform technology. The AOS is, in essence, the
result of a marriage between advances in iodine electrochemistry and materials engineering of carbon compounds, and data suggest it
could lead to substantial economic and water savings in multiple industries. A pilot project for the AOS, as with any technology,
is crucial to prove its reliability to industry stakeholders as well the capital cost and operating costs of our technology
at-scale. These data will be critical to pave the way for future market adoption.
BioLargo Water’s President Dr. Richard Smith commented on this news, “This contribution will allow BioLargo Water to move
forward with a long-term pilot in wastewater treatment to validate its ability to meet reuse standards. The continued support from
NRC IRAP indicates the potential of our technology and demonstrates the need for our AOS on the global market. We thank the
Government of Canada and NRC IRAP for their support.”
BioLargo, Inc.’s President and CEO Dennis Calvert also commented, “This pre-commercial pilot is an important step toward
commercial production of our flagship AOS product. Our engineering team is working with our Canadian researchers and industrial
stakeholders to push this product toward client installations and sales. We are working with a facility that processes six to eight
thousand chickens per week, and we believe this project will directly lead to significant water and money savings for this client,
as well as help prove up our value proposition in real-world conditions. We expect to operate our AOS on-site for an extended
period of time under real life operating conditions.”
As is true with all novel technologies, field testing is critical to evaluate and refine the data in support of durability,
capital cost, operating cost, and extended performance metrics. Calvert commented, “We believe our AOS technology can help the food
processing industry improve its water overall self-sufficiency, reduce wastewater disposal costs and improve its continued march to
improve its commitment to sustainability. We also believe the deployment of the AOS will save this industry money and water,
both long term and short term, and the data we will develop in this commercial pilot will help us validate those claims.”
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology incubator and environmental engineering company driven by a mission to “make life
better” by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean
water, clean air, and advanced wound care. We incubate disruptive technologies by providing the capital, support, and expertise to
expedite them from “cradle” to “maturity” (www.biolargo.com). Our engineering division features experienced professional engineers
dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking
them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that
contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System “AOS”, a disruptive industrial
water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency
and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to
promote infection control and regenerative tissue therapy.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and
uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements,
including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities
and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K.
Company Contact
Dennis Calvert
President and CEO
BioLargo, Inc.
949-643-9540 x2
